Deborah Daccord discusses the regulatory complexities and community based issues involved in substance use disorder and opioid addiction treatment center transactions as well as the uptick...

In recent healthcare mergers and acquisitions, we have seen the parties increasingly focus on the survival length of the representations in purchase agreements.

Lawmakers are again eyeing ways to modernize the Medicare system, including a revamping of the identification cards used by Medicare beneficiaries.

Joe Price provides and overview of the leveraged finance market and discusses unique deal points for private equity healthcare transactions.

Dynamic changes in the nation’s health care delivery systems have been prompted, in part, by the implementation of the Patient Protection and Affordable Care Act.

The Massachusetts Division of Unemployment assistance continues to audit Massachusetts employers, making sure that anyone doing business in Massachusetts is either meeting the requirements of the Fair Share Law or paying the appropriate penalty ($73.75 per employee per quarter).

Earlier this week the Massachusetts House of Representatives voted 128-22 to repeal the Massachusetts Pharmaceutical and Medical Device Manufacturer Code of Conduct (often called the "gift ban" law).

Our colleagues at ML Strategies, Eli Greenspan and Alexander Hecht, recently published an article on the impact of state Medicaid program transitions to managed care on brain injury waiver populations.

Health Law Diagnosed returns! We asked the Health Law team to share their health law–focused resolutions for 2022 and discuss how they are helping clients — and colleagues — navigate the continued challenges and opportunities of the current era.

Kevin's analysis highlights what many experienced practitioners already knew anecdotally to be true: that the volume of health qui tam litigation has grown rapidly in recent years.

Congress has two weeks to finish up a partial spending deal.

This week, Congress is expected to pass a two-week extension to avoid a partial government shutdown. This will give both sides time work out the remaining spending bills,

This week, the focus shifts back to the Congressional push around addressing the opioid epidemic after the President's speech on drug pricing was postponed. Both committees of jurisdiction ...

This week, the House Energy & Commerce Committee will hold its second round markup of opioid-related legislation.

ML Strategies has posted its weekly Health Care Reform Update.

This publication provides information on implementation of the ACA, Congressional initiatives affecting the health care industry, and health regulatory developments.

After finalizing three key guidance documents on biosimilars at the end of April (reported on our blog here), yesterday FDA released another "Question and Answer" guidance in draft form.

In July, the Food Court in the Northern District of California asked FDA to opine on the proper use and application of "whether and under what circumstances food products containing ingredients produced using bioengineered seed may or may not be labeled 'Natural'," and stayed the case against Gruma for six months.

A recent Massachusetts Superior Court decision recognizes a claim against a hospital for "negligent credentialing."

Mintz’s Managed Care, PBMs & Pharmacies Practice is pleased to present its quarterly publication, PBM Policy and Legislative Update. This issue examines key federal and state developments from mid-February 2026 through June 2026 impacting PBMs and the broader prescription drug supply chain.